Cancer-testis antigens

Details for Australian Patent Application No. 2005282489 (hide)

Owner Memorial Sloan-Kettering Cancer Center Cornell Research Foundation, Inc. Ludwig Institute for Cancer Research

Inventors Scanlan, Matthew; Jongeneel, C. Victor; Old, Lloyd J.; Chen, Yao-Tseng; Simpson, Andrew J G.

Agent Pizzeys

Pub. Number AU-A-2005282489

PCT Pub. Number WO2006/029176

Priority 60/607,821 08.09.04 US; 60/664,791 24.03.05 US

Filing date 8 September 2005

Wipo publication date 16 March 2006

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

19 April 2007 PCT application entered the National Phase

  PCT publication WO2006/029176 Priority application(s): WO2006/029176

23 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005282491-Colorant treated ion exchange resins, method of making, heat transfer systems and assemblies containing the same, and method of use

2005282480-Treatment of diseases using nalmefene and its analgos